Acquisition of Boston biotech for up to $120M a 'validation' of Ora's model
French drug developer NiCox S.A. last week announced plans to buy Aciex Therapeutics
Nicox to acquire Aciex Therapeutics, Inc.
Significant step forward in Nicox’s strategy of creating an international ophthalmic company built around therapeutics and diagnostics
ARVO Comes to The City of Magic
Highlights from the posters and papers presented at the 2014
ARVO meeting in Orlando.
Including Clinical Trials at Your Practice
First-time investigators should consider several matters when preparing for a clinical trial.
Resistance Fighters: An Antibiotics Update
Antibiotic innovation has slowed, allowing drug resistance to catch up, but there is still hope for the future of anti-infectives.
Innate Immunity: A Question of Balance
A look at the processes of immunity and ocular inflammation,
and new avenues for disease therapy.
It all adds up to Ora
Check out our latest Video